מצגת מיום העיון גידולי מוח 2014
10:40
סגור לתגובות על מצגת מיום העיון גידולי מוח 2014
מצגת מיום העיון שנערך ב-2014
How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach
12:22
סגור לתגובות על How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach
Marcio Nucci and Elias Anaissie,
Blood 2014 :blood-2014-04-516211
Autoimmune hemolytic anemia: current understanding of pathophysiology
10:44
סגור לתגובות על Autoimmune hemolytic anemia: current understanding of pathophysiology
מצגת מאת פרופ' חנה תמרי.
Paroxysmal nocturnal hemoglobinuria
10:18
סגור לתגובות על Paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare bonemarrow failure disorder that manifests with hemolytic anemia, thrombosis, and peripheral
Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor – PNET
16:17
סגור לתגובות על Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor – PNET
Current Treatment Options in Neurology, 2013, Volume 15, Number 5, Page 593
Kevin C. De Braganca, Roger J.
Medulloblastoma – translating discoveries from the bench to the bedside
16:13
סגור לתגובות על Medulloblastoma – translating discoveries from the bench to the bedside
Amar J. Gajjar & Giles W. Robinson
Nature Reviews Clinical Oncology volume11, pages714–722 (2014)
A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 months Old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue vs. the Same Therapy Without Methotrexate
17:00
אין תגובות
ACNS0334
STUDY CO-CHAIR: Claire Mazewski, M.D. Stewart Kellie, MD
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology
16:05
סגור לתגובות על The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology
This is a single guideline replacing two separate guidelines on diagnosis and management respectively, published in 2004 (Laffan et al, 2004;
